National Institutes of Health Award a $1.7M SBIR Grant to MicroTransponder to Develop a Neurostimulation-Based Therapy to Treat Tinnitus
MicroTransponder, Inc., a privately-held medical device company, announced that it has been awarded a $1.7M SBIR grant from the National Institute on Deafness and Other Communication Disorders (NIDCD) to develop a neurostimulation-based therapy for the treatment of Tinnitus. This project builds... - September 01, 2010
CEO Will Rosellini and MicroTransponder Inc. Named Finalists for the 10th Annual Tech Titans Awards
The MTBC has named CEO Will Rosellini a finalist for the Tech Innovator category and MicroTransponder a finalist for the Emerging Company Horizon category for the 10th Annual Tech Titan Awards in Texas. - August 17, 2010
National Institute of Mental Health Awards a Phase I SBIR Grant to MicroTransponder to Develop a Neurostimulation-based Therapy to Treat Post Traumatic Stress Disorder
MicroTransponder, Inc., a privately-held medical device company, announced that it has been awarded a Phase I SBIR grant from the National Institute of Mental Health (NIMH) to develop a neurostimulation-based therapy for the treatment of Post Traumatic Stress Disorder (PTSD). This project will... - February 19, 2010
MicroTransponder Inc. Awarded Patent for Wireless Neurostimulation Device
MicroTransponder Inc., a privately-held medical device company, announced it has been awarded a neurostimulation patent for a "Grooved Electrode and Wireless Microtransponder System" (U.S. Patent No. 7,630,771) from the U.S. Patent and Trademark Office. The patent is MicroTransponder's... - December 09, 2009
MicroTransponder CEO Will Rosellini Named Graduate Student Entrepreneur of the Year by the Entrepreneurs’ Organization
MicroTransponder CEO Will Rosellini named Graduate Student Entrepreneur of the Year by the Entrepreneurs’ Organization for founding a dynamic medical device company focused on neurostimulation for chronic pain and other neurological disorders. - November 20, 2009
MicroTransponder Announces Development Agreement with Paragon Innovations to Design an External Controller for SAINT™ System
MicroTransponder Inc., a privately-held medical device company developing a suite of wireless neuroneuroprostheses, has just announced that it has entered into a development agreement with Paragon Innovations, Inc. to design a rechargeable, battery-powered, external controller for the SAINT™... - September 29, 2009
MicroTransponder Announces Contract Development Agreement with AsicNORTH to Design Integrated Circuits for SAINT™ Device
MicroTransponder Inc., a privately held medical device company developing a suite of wireless neurostimulators, has just announced that they have entered into a development agreement with asicNorth to design an application specific integrated circuit (ASIC) circuits for the SAINT™ device. - September 24, 2009
MicroTransponder Names Frank McEachern as Executive Chairman of the Board
Founding member Frank McEachern becomes Executive Chairman of the Board in addition to his roles as CFO and General Counsel for MicroTransponder. - July 15, 2009
MicroTransponder Awarded "Most Promising Life Science Technology Company - 2009" at Rice Alliance Venture Forum
MicroTransponder awarded “Most Promising Life Science Technology Company - 2009” at Rice Alliance Venture Forum and announces executive promotions of Jordan Curnes to President and Frank McEachern to Chairman of the Board. Rosellini will be interviewed on the BusinessMakers radio show this Saturday, June 20. The interview will be available on their website www.thebusinessmakers.com. - June 18, 2009
MicroTransponder CEO Will Rosellini to Testify Before the U.S. House of Representatives Concerning Neurotechnology
CEO Will Rosellini will testify before the U.S. House of Representatives regarding the Federal SBIR program on Wednesday, April 22. SBIR awards to MicroTransponder have funded neurotechnology research for TBI, Tinnitus, and PTSD resulting in potential new treatments for soldiers. - April 19, 2009